PortfoliosLab logo
EXAS vs. ACHC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EXAS and ACHC is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

EXAS vs. ACHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exact Sciences Corporation (EXAS) and Acadia Healthcare Company, Inc. (ACHC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

EXAS:

0.15

ACHC:

-1.10

Sortino Ratio

EXAS:

0.56

ACHC:

-1.82

Omega Ratio

EXAS:

1.08

ACHC:

0.73

Calmar Ratio

EXAS:

0.06

ACHC:

-0.82

Martin Ratio

EXAS:

0.20

ACHC:

-1.46

Ulcer Index

EXAS:

22.45%

ACHC:

43.39%

Daily Std Dev

EXAS:

58.98%

ACHC:

55.28%

Max Drawdown

EXAS:

-98.01%

ACHC:

-98.67%

Current Drawdown

EXAS:

-63.60%

ACHC:

-70.64%

Fundamentals

Market Cap

EXAS:

$10.64B

ACHC:

$2.41B

EPS

EXAS:

-$5.55

ACHC:

$2.08

PEG Ratio

EXAS:

-1.07

ACHC:

1.32

PS Ratio

EXAS:

3.76

ACHC:

0.76

PB Ratio

EXAS:

4.42

ACHC:

0.78

Total Revenue (TTM)

EXAS:

$2.83B

ACHC:

$3.16B

Gross Profit (TTM)

EXAS:

$1.93B

ACHC:

$2.46B

EBITDA (TTM)

EXAS:

-$848.74M

ACHC:

$534.43M

Returns By Period

In the year-to-date period, EXAS achieves a 0.41% return, which is significantly higher than ACHC's -34.05% return. Over the past 10 years, EXAS has outperformed ACHC with an annualized return of 7.84%, while ACHC has yielded a comparatively lower -9.64% annualized return.


EXAS

YTD

0.41%

1M

35.69%

6M

14.37%

1Y

11.99%

5Y*

-7.63%

10Y*

7.84%

ACHC

YTD

-34.05%

1M

9.37%

6M

-30.86%

1Y

-60.59%

5Y*

0.19%

10Y*

-9.64%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EXAS vs. ACHC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EXAS
The Risk-Adjusted Performance Rank of EXAS is 5454
Overall Rank
The Sharpe Ratio Rank of EXAS is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 5353
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 5353
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 5454
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 5353
Martin Ratio Rank

ACHC
The Risk-Adjusted Performance Rank of ACHC is 44
Overall Rank
The Sharpe Ratio Rank of ACHC is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of ACHC is 33
Sortino Ratio Rank
The Omega Ratio Rank of ACHC is 22
Omega Ratio Rank
The Calmar Ratio Rank of ACHC is 44
Calmar Ratio Rank
The Martin Ratio Rank of ACHC is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EXAS vs. ACHC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Exact Sciences Corporation (EXAS) and Acadia Healthcare Company, Inc. (ACHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current EXAS Sharpe Ratio is 0.15, which is higher than the ACHC Sharpe Ratio of -1.10. The chart below compares the historical Sharpe Ratios of EXAS and ACHC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

EXAS vs. ACHC - Dividend Comparison

Neither EXAS nor ACHC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

EXAS vs. ACHC - Drawdown Comparison

The maximum EXAS drawdown since its inception was -98.01%, roughly equal to the maximum ACHC drawdown of -98.67%. Use the drawdown chart below to compare losses from any high point for EXAS and ACHC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

EXAS vs. ACHC - Volatility Comparison

The current volatility for Exact Sciences Corporation (EXAS) is 11.88%, while Acadia Healthcare Company, Inc. (ACHC) has a volatility of 18.50%. This indicates that EXAS experiences smaller price fluctuations and is considered to be less risky than ACHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

EXAS vs. ACHC - Financials Comparison

This section allows you to compare key financial metrics between Exact Sciences Corporation and Acadia Healthcare Company, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


300.00M400.00M500.00M600.00M700.00M800.00M20212022202320242025
706.79M
770.51M
(EXAS) Total Revenue
(ACHC) Total Revenue
Values in USD except per share items

EXAS vs. ACHC - Profitability Comparison

The chart below illustrates the profitability comparison between Exact Sciences Corporation and Acadia Healthcare Company, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
70.8%
96.3%
(EXAS) Gross Margin
(ACHC) Gross Margin
EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.

ACHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a gross profit of 742.16M and revenue of 770.51M. Therefore, the gross margin over that period was 96.3%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.

ACHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported an operating income of 78.50M and revenue of 770.51M, resulting in an operating margin of 10.2%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.

ACHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a net income of 8.37M and revenue of 770.51M, resulting in a net margin of 1.1%.